Physician profile
Brian M Mannari
NPI 1588008726
$5,378.73
in general payments reported to CMS, 2019-2025
15 companies · $767 in 2025
The $767 reported for 2025 was more than what 83% of Oral and Maxillofacial Surgery providers received nationally (typical 2025 total: $150).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $412 · 2020: $431 · 2021: $1,348 · 2022: $846 · 2023: $645 · 2024: $929 · 2025: $767.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,026 · Entertainment: $316.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,025.81 |
| Entertainment | $315.53 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Salvin Dental Specialties, INC. | $1,091.33 | 2020-2021 | |
| Straumann USA LLC | $890.27 | 2021-2025 | |
| Nobel Biocare USA | $749.13 | 2019-2022 | |
| Depuy Synthes Sales INC. | $680.48 | 2022-2025 | Matrixorthognathic, Trumatch, Na |
| Stryker Corporation | $523.31 | 2019-2025 | Patient-Fitted Tmj Reconstructive Prosthesis System, Na, Medpor Titan |
| Keystone Dental INC. | $315.53 | 2023 | |
| Biohorizons Implant Systems INC. | $303.37 | 2022-2025 | Biohorizons, Biohorizons Dental Implants |
| Kls-Martin L.P. | $285.14 | 2022-2025 | |
| Zimmer Biomet Holdings, INC. | $126.18 | 2020-2021 | |
| Geistlich Pharma, North America, INC. | $124.91 | 2021-2025 | Bio-Materials, Biomaterials |
| Medical Device Business Services, INC. | $83.14 | 2023 | Matrixmidface, Matrixorthognathic, Matrixmandible |
| Zimvie INC. | $75.95 | 2022-2023 | |
| Southern Implants North America INC | $59.00 | 2021 | |
| Orapharma, A Division of Bausch Health US, LLC | $38.90 | 2022-2024 | Arestin |
| Mvp Orthopedics INC | $32.09 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Brian Mannari listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.